References
- Ross EJ, Linch DC. Cushing's syndrome–killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 1982; 2:646-9; PMID:6125785; http://dx.doi.org/10.1016/S0140-6736(82)92749-0
- Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93:1526-40; PMID:18334580; http://dx.doi.org/10.1210/jc.2008-0125
- García-Porrúa C, González-Gay MA, Vázquez-Caruncho M, López-Lazaro L, Lueiro M, Fernández ML, Alvarez-Ferreira J, Pujol RM. Erythema nodosum: etiologic and predictive factors in a defined population. Arthritis Rheum 2000; 43:584-92; PMID:10728752; http://dx.doi.org/10.1002/1529-0131(200003)43:3<584::AID-ANR15>3.0.CO;2-6
- da Mota F, Murray C, Ezzat S. Overt immune dysfunction after Cushing's syndrome remission: a consecutive case series and review of the literature. J Clin Endocrinol Metab 2011; 96:E1670-4; PMID:21816785; http://dx.doi.org/10.1210/jc.2011-1317
- McDaniel WE, Bard JW, Blakey LW, Hamilton RD. Sarcoid nodules in Cushing's disease. Arch Dermatol 1970; 101:356-8; PMID:5414894; http://dx.doi.org/10.1001/archderm.1970.04000030100017
- Takenaka K, Yanase T, Takayanagi R, Haji M, Ikuyama S, Nawata H. Cushing's disease preceding sarcoidosis. Intern Med 1995; 34:580-3; PMID:7549148; http://dx.doi.org/10.2169/internalmedicine.34.580
- Marzano AV, Gasparini G, Caputo R, Alessi E. Subcutaneous sarcoidosis following hypophysectomy for pituitary microadenoma inducing Cushing's disease. Int J Dermatol 1998; 37:798; PMID:9802695
- Maldonado M, Orlander P, Roshan SY, McCutcheon IE, Cleary KR, Friend KE. Sarcoidosis after surgically induced remission of Cushing's disease. Endocr Pract 1999; 5:43-5; PMID:15251702; http://dx.doi.org/10.4158/EP.5.1.43
- Fichtel JC, Duckworth AKW, Soares T, Lesher JL Jr. Subcutaneous sarcoidosis presenting after treatment of Cushing's disease. J Am Acad Dermatol 2006; 54:360-1; PMID:16443078; http://dx.doi.org/10.1016/j.jaad.2005.03.042
- Pivonello R, De Martino MC, De Leo M, Tauchmanovà L, Faggiano A, Lombardi G, Colao A. Cushing's syndrome: aftermath of the cure. Arq Bras Endocrinol Metabol 2007; 51:1381-91; PMID:18209877; http://dx.doi.org/10.1590/S0004-27302007000800025
- Böhm M, Luger TA, Tobin DJ, García-Borrón JC. Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol 2006; 126:1966-75; PMID:16912693; http://dx.doi.org/10.1038/sj.jid.5700421
- Brzoska T, Luger TA, Maaser C, Abels C, Böhm M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 2008; 29:581-602; PMID:18612139; http://dx.doi.org/10.1210/er.2007-0027
- Saag KG, Furst DE. Major side effects of systemic glucocorticoids. In: Basow DS, editor. UpToDate. UpToDate; 2013.